Azhar Kalim has been appointed chief commercial officer, Quotient Clinical. Mr. Kalim will lead the commercial team focusing on Quotient’s strategy to further develop its global commercial footprint following two recent U.S. acquisitions.   Quotient’s capabilities include formulation development, GMP drug product manufacturing and early stage clinical trials. The company recently acquired SeaView Research, a specialist early phase clinical pharmacology business, and QS Pharma, a small molecule...